Elevated levels of VNN1 have been linked to chronic inflammation and metabolic disorders, such as obesity, T2DM, and non-alcoholic fatty liver disease (NAFLD) (21, 22). This evidence concerns the gene VNN1 and metabolic dysfunction-associated steatotic liver disease.